Table 2.
Placebo (N=34) | Supplement (N=34) | |
---|---|---|
Age (years) | 23.4 (1.7) | 23.9 (2.0) |
Female | 14 (41%) | 16 (47%) |
Race | ||
White | 25 (74%) | 21 (62%) |
Black | 0 (0%) | 2 (6%) |
Asian | 5 (15%) | 7 (21%) |
Other | 4 (12%) | 4 (12%) |
Sagittal abdominal diameter (cm) | 18.2 (2.7) | 17.7 (2.2) |
Beck Anxiety* | ||
Median (IQR) | 2.5 (1–4.5) | 3.5 (2–6) |
Range | 0–20 | 0–14 |
CES-D* | ||
Median (IQR) | 5.25 (3.5–7.5) | 6.25 (4–8) |
Range | 1–16.5 | 1–15.5 |
Data are mean (SD) or n (%) except where noted. There were no significant group differences on any of the participant characteristics (p>0.1 for all tests).
Average of the two baseline visits.